• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The management of infections and antibiotic therapy: a European survey.

作者信息

Halls G A

机构信息

Medical Market Studies Ltd, Pinner, Middlesex, UK.

出版信息

J Antimicrob Chemother. 1993 Jun;31(6):985-1000. doi: 10.1093/jac/31.6.985.

DOI:10.1093/jac/31.6.985
PMID:8360135
Abstract

A survey was undertaken in the five largest European countries in 1990/91 to measure the incidence of infectious diseases and record their antibiotic treatment, and usage as prophylaxis in acute general hospitals with over 300 beds. A representative sample of between 1234 and 1954 patient records were received for each country, with each participating clinician providing eight to ten records. Data were projected up to national totals. There were similarities between the patients across the countries, 50% of patients received surgery at some time in their hospital stay and in 45% the first antibiotic usage was as prophylaxis. In one fifth of the 55% treated for an infection, that infection was hospital acquired, but these 20% of patients accounted for 30% of total days in hospital for patients treated for infection. Infections of the lower respiratory tract, urinary tract and abdomen accounted for 75% of all infection cases. In 85% of infection cases, initial treatment was empirical. Overall, no culture and sensitivity data were reported by the end of treatment in over 50% of patients, with appreciable variation between the countries. In the UK, 60% of in-patient treatment was with oral antibiotics; in Italy, over 80% was injectable with over half that intramuscular. Germany had the highest rate of intravenous administration at nearly 60% of treatment days. Combination usage was highest, with over 30% of patient treatment days, in France and Spain, but Germany and Italy had the lowest usage at 21% and 16%. Mean duration of administration of antibiotics was shortest in the UK, eight days for infection and four days for prophylaxis, with France the longest at 12 days for infection, and Italy for prophyalxis at over five days. The UK had the highest rate of discharge on antibiotic treatment at over 30% of patients. Initial therapy was effective in about 90% of patients, but the UK, with the shortest durations and the greatest use of older antibiotics often as monotherapy and administered orally, had the highest rate of initial failure (> 10%) of both treatment of infection and prophylaxis. The result of initial failure was a significant prolongation of both hospital stay and antibiotic treatment. The 10% of initial treatment failures accounted for 15% of antibiotic usage in the UK. In France initial treatment failures were treated for twice the length of those in whom the initial therapy was successful.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

相似文献

1
The management of infections and antibiotic therapy: a European survey.
J Antimicrob Chemother. 1993 Jun;31(6):985-1000. doi: 10.1093/jac/31.6.985.
2
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.降钙素原用于启动或停用急性呼吸道感染患者的抗生素治疗。
Evid Based Child Health. 2013 Jul;8(4):1297-371. doi: 10.1002/ebch.1927.
3
Breast augmentation, antibiotic prophylaxis, and infection: comparative analysis of 1,628 primary augmentation mammoplasties assessing the role and efficacy of antibiotics prophylaxis duration.乳房增大术、抗生素预防用药和感染:对 1628 例原发性隆乳术的对比分析,评估抗生素预防用药持续时间的作用和疗效。
Aesthetic Plast Surg. 2010 Feb;34(1):42-7. doi: 10.1007/s00266-009-9427-8. Epub 2009 Oct 20.
4
Antibiotic treatment patterns across Europe in patients with complicated skin and soft-tissue infections due to meticillin-resistant Staphylococcus aureus: a plea for implementation of early switch and early discharge criteria.欧洲耐甲氧西林金黄色葡萄球菌所致复杂性皮肤软组织感染患者的抗生素治疗模式:呼吁实施早期转换和早期出院标准。
Int J Antimicrob Agents. 2014 Jul;44(1):56-64. doi: 10.1016/j.ijantimicag.2014.04.007. Epub 2014 May 16.
5
Variation in paediatric hospital antibiotic guidelines in Europe.欧洲儿童医院抗生素指南的差异。
Arch Dis Child. 2016 Jan;101(1):72-6. doi: 10.1136/archdischild-2015-308255. Epub 2015 Sep 28.
6
Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey.社区获得性下呼吸道感染的初始抗生素治疗:一项欧洲调查。
Eur Respir J. 1996 Aug;9(8):1590-5. doi: 10.1183/09031936.96.09081590.
7
Trends in infections and antibiotic usage in a community hospital.
Am J Infect Control. 1987 Feb;15(1):7-15. doi: 10.1016/0196-6553(87)90070-8.
8
Consequences of inappropriate initial empiric parenteral antibiotic therapy among patients with community-acquired intra-abdominal infections in Spain.西班牙社区获得性腹腔内感染患者初始经验性肠外抗生素治疗不当的后果。
Scand J Infect Dis. 2007;39(11-12):947-55. doi: 10.1080/00365540701449377. Epub 2007 Jun 5.
9
[Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].利奈唑胺治疗肌肉骨骼系统耐抗生素革兰氏阳性菌感染
Acta Chir Orthop Traumatol Cech. 2006 Oct;73(5):329-33.
10
[Study of the prevalence of nosocomial infections and associated factors in the two university hospitals of Lubumbashi, Democratic Republic of Congo].[刚果民主共和国卢本巴希两所大学医院医院感染患病率及其相关因素研究]
Pan Afr Med J. 2016 Jul 27;24:275. doi: 10.11604/pamj.2016.24.275.7626. eCollection 2016.

引用本文的文献

1
Evolution of Antibiotic Use and Cost in Patients with Community-Acquired Pneumonia.
Clin Drug Investig. 2002 Sep;22(9):601-608. doi: 10.2165/00044011-200222090-00005.
2
How to educate prescribers in antimicrobial stewardship practices.如何对开处方者进行抗菌药物管理实践教育。
Virulence. 2013 Feb 15;4(2):192-202. doi: 10.4161/viru.23706. Epub 2013 Jan 29.
3
Subcellular expression pattern and role of IL-15 in pneumococci induced lung epithelial apoptosis.白细胞介素-15在肺炎球菌诱导的肺上皮细胞凋亡中的亚细胞表达模式及作用
Histochem Cell Biol. 2008 Jul;130(1):165-76. doi: 10.1007/s00418-008-0414-y. Epub 2008 Mar 26.
4
Moxifloxacin in the management of exacerbations of chronic bronchitis and COPD.莫西沙星用于治疗慢性支气管炎急性加重和慢性阻塞性肺疾病
Int J Chron Obstruct Pulmon Dis. 2007;2(3):191-204.
5
Intravenous and oral antibiotics in respiratory tract infection: an international observational study of hospital practice.呼吸道感染中静脉注射与口服抗生素治疗:一项关于医院实践的国际观察性研究
Pharm World Sci. 2002 Dec;24(6):247-55. doi: 10.1023/a:1021522226178.
6
Antimicrobial utilization and bacterial resistance at three different hospitals.
Eur J Epidemiol. 2001;17(4):375-83. doi: 10.1023/a:1012742314070.
7
Role of global surveillance in combating bacterial resistance.全球监测在对抗细菌耐药性中的作用。
Drugs. 2001;61(2):167-73. doi: 10.2165/00003495-200161020-00002.
8
Place of parenteral cephalosporins in the ambulatory setting: clinical evidence.胃肠外头孢菌素在门诊环境中的应用:临床证据
Drugs. 2000;59 Suppl 3:37-46; discussion 47-9. doi: 10.2165/00003495-200059003-00005.
9
Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages.门诊护理中的胃肠外头孢菌素治疗:利弊
Drugs. 2000;59 Suppl 3:19-28; discussion 47-9. doi: 10.2165/00003495-200059003-00003.
10
Epidemiology and pharmacoeconomic issues relating to acute respiratory tract infections and acute uncomplicated infections of the urinary tract.与急性呼吸道感染和急性单纯性尿路感染相关的流行病学和药物经济学问题。
Pharmacoeconomics. 1994;5(Suppl 2):1-10. doi: 10.2165/00019053-199400052-00003.